Lv11
45 积分 2020-10-23 加入
PROTAC protein degraders to drug the undruggable enter phase 3 trials
21天前
已关闭
Protein degraders push into novel target space
21天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
28天前
已完结
Folic Acid Supplementation to Prevent Neural Tube Defects
1个月前
已完结
New epilepsy therapies in development
1个月前
已完结
Navacaprant, a Novel Kappa Opioid Receptor Antagonist for Major Depressive Disorder: A Randomized Placebo-Controlled Phase 2 Trial
2个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2个月前
已完结
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
2个月前
已完结
中国慢性胃炎诊治指南(2022年，上海)
2个月前
已完结
RNAi-based drug design: considerations and future directions
4个月前
已完结
皖公网安备34019202002308
